HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PharmaPrint Joint Ventures, Vendor Payment Plan Talks Underway

This article was originally published in The Tan Sheet

Executive Summary

PharmaPrint is counting on several strategic initiatives, including negotiating payment plans with vendors and selling shares of its privately held Internet company, to counteract losses stemming from a terminated agreement with American Home Products.

You may also be interested in...



PharmaPrint

Steven Bowman tapped interim CEO, filling in until a replacement is found for Richard Piazza, the company announces May 11. Piazza stepped down from the president, CEO and chairman of the board positions he assumed last November from Elliot Friedman, who remains a board member (1"The Tan Sheet" Oct. 18, 1999, p. 20). Former PharmaPrint corporate counsel and board member Phil Trad temporarily assumed the responsibilities of president, treasurer and company secretary; the board remains without a chairman. Although a search is underway, PharmaPrint says restructuring debt and shoring up the firm's finances are more pressing priorities than recruiting a president or permanent replacements for the other positions (2"The Tan Sheet" Feb. 28, p. 8)

Centrum Herbals Supply Terms, Technology Contested By AHP, PharmaPrint

American Home Products and PharmaPrint are suing each other over alleged breaches of license and supply agreements for Centrum Herbals. PharmaPrint additionally is charging AHP with using PharmaPrint's technology to create its own line of combination products containing an herbal and one vitamin, mineral and/or other nutrient, to be launched within six months.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel